双極性障害薬＆治療のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Bipolar Disorder Drugs and Treatment Market Insights, Forecast to 2028

• レポートコード：QY2207E09348 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界の双極性障害薬＆治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に双極性障害薬＆治療の世界市場のxxx％を占める「気分安定薬」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の双極性障害薬＆治療の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの双極性障害薬＆治療市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの双極性障害薬＆治療市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 双極性障害薬＆治療のグローバル主要メーカーには、AbbVie Inc.、Glaxo SmithKline (GSK)、Eli Lily and Company、Janssen Pharmaceuticals、Johnson & Johnson、Astellas Pharma Inc、Bristol Myers Squibb、Gedeon Richter PLC.、H. Lundbeck A/S、Pfizer Inc.、Novartis AG、Otsuka Holdings Co. Ltd、Validus Pharmaceuticals LLC.などがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 双極性障害薬＆治療市場は、種類と用途によって区分されます。世界の双極性障害薬＆治療市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 気分安定薬、抗けいれん薬、抗精神病薬、抗うつ薬、抗不安薬 【用途別セグメント】 病院、診療所 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 双極性障害薬＆治療製品概要 - 種類別市場（気分安定薬、抗けいれん薬、抗精神病薬、抗うつ薬、抗不安薬） - 用途別市場（病院、診療所） - 調査の目的 ・エグゼクティブサマリー - 世界の双極性障害薬＆治療販売量予測2017-2028 - 世界の双極性障害薬＆治療売上予測2017-2028 - 双極性障害薬＆治療の地域別販売量 - 双極性障害薬＆治療の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別双極性障害薬＆治療販売量 - 主要メーカー別双極性障害薬＆治療売上 - 主要メーカー別双極性障害薬＆治療価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（気分安定薬、抗けいれん薬、抗精神病薬、抗うつ薬、抗不安薬） - 双極性障害薬＆治療の種類別販売量 - 双極性障害薬＆治療の種類別売上 - 双極性障害薬＆治療の種類別価格 ・用途別市場規模（病院、診療所） - 双極性障害薬＆治療の用途別販売量 - 双極性障害薬＆治療の用途別売上 - 双極性障害薬＆治療の用途別価格 ・北米市場 - 北米の双極性障害薬＆治療市場規模（種類別、用途別） - 主要国別の双極性障害薬＆治療市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの双極性障害薬＆治療市場規模（種類別、用途別） - 主要国別の双極性障害薬＆治療市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の双極性障害薬＆治療市場規模（種類別、用途別） - 主要国別の双極性障害薬＆治療市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の双極性障害薬＆治療市場規模（種類別、用途別） - 主要国別の双極性障害薬＆治療市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの双極性障害薬＆治療市場規模（種類別、用途別） - 主要国別の双極性障害薬＆治療市場規模（トルコ、サウジアラビア） ・企業情報 AbbVie Inc.、Glaxo SmithKline (GSK)、Eli Lily and Company、Janssen Pharmaceuticals、Johnson & Johnson、Astellas Pharma Inc、Bristol Myers Squibb、Gedeon Richter PLC.、H. Lundbeck A/S、Pfizer Inc.、Novartis AG、Otsuka Holdings Co. Ltd、Validus Pharmaceuticals LLC. ・産業チェーン及び販売チャネル分析 - 双極性障害薬＆治療の産業チェーン分析 - 双極性障害薬＆治療の原材料 - 双極性障害薬＆治療の生産プロセス - 双極性障害薬＆治療の販売及びマーケティング - 双極性障害薬＆治療の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 双極性障害薬＆治療の産業動向 - 双極性障害薬＆治療のマーケットドライバー - 双極性障害薬＆治療の課題 - 双極性障害薬＆治療の阻害要因 ・主な調査結果

Drug therapy is currently the core method of treating bipolar disorder, that is, the use of emotional stabilizers to adjust the patient’s mood. Bipolar disorder is complex and difficult to control. The drug effect of emotional stabilizers can help patients to suppress their emotions when they are too high, to increase their emotions when they are depressed, to stabilize their emotions at a normal level, and to effectively prevent the recurrence of bipolar disorder. The quickest and most effective approach may be convulsive-free electroconvulsive therapy.
Market Analysis and Insights: Global Bipolar Disorder Drugs and Treatment Market
Due to the COVID-19 pandemic, the global Bipolar Disorder Drugs and Treatment market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Mood Stabilizers accounting for % of the Bipolar Disorder Drugs and Treatment global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Bipolar Disorder Drugs and Treatment market size is valued at US$ million in 2021, while the US and Europe Bipolar Disorder Drugs and Treatment are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Bipolar Disorder Drugs and Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Bipolar Disorder Drugs and Treatment include AbbVie Inc., Glaxo SmithKline (GSK), Eli Lily and Company, Janssen Pharmaceuticals, Johnson & Johnson, Astellas Pharma Inc, Bristol Myers Squibb, Gedeon Richter PLC. and H. Lundbeck A/S, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Bipolar Disorder Drugs and Treatment Scope and Segment
Bipolar Disorder Drugs and Treatment market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Bipolar Disorder Drugs and Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Mood Stabilizers
Anticonvulsants
Antipsychotic Drugs
Antidepressant Drugs
Anti-Anxiety Drugs
Segment by Application
Hospital
Clinic
By Company
AbbVie Inc.
Glaxo SmithKline (GSK)
Eli Lily and Company
Janssen Pharmaceuticals
Johnson & Johnson
Astellas Pharma Inc
Bristol Myers Squibb
Gedeon Richter PLC.
H. Lundbeck A/S
Pfizer Inc.
Novartis AG
Otsuka Holdings Co. Ltd
Validus Pharmaceuticals LLC.
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Bipolar Disorder Drugs and Treatment Product Introduction
1.2 Market by Type
1.2.1 Global Bipolar Disorder Drugs and Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Mood Stabilizers
1.2.3 Anticonvulsants
1.2.4 Antipsychotic Drugs
1.2.5 Antidepressant Drugs
1.2.6 Anti-Anxiety Drugs
1.3 Market by Application
1.3.1 Global Bipolar Disorder Drugs and Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Bipolar Disorder Drugs and Treatment Sales Estimates and Forecasts 2017-2028
2.2 Global Bipolar Disorder Drugs and Treatment Revenue Estimates and Forecasts 2017-2028
2.3 Global Bipolar Disorder Drugs and Treatment Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Bipolar Disorder Drugs and Treatment Sales by Region
2.4.1 Global Bipolar Disorder Drugs and Treatment Sales by Region (2017-2022)
2.4.2 Global Sales Bipolar Disorder Drugs and Treatment by Region (2023-2028)
2.5 Global Bipolar Disorder Drugs and Treatment Revenue by Region
2.5.1 Global Bipolar Disorder Drugs and Treatment Revenue by Region (2017-2022)
2.5.2 Global Bipolar Disorder Drugs and Treatment Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Bipolar Disorder Drugs and Treatment Sales by Manufacturers
3.1.1 Global Top Bipolar Disorder Drugs and Treatment Manufacturers by Sales (2017-2022)
3.1.2 Global Bipolar Disorder Drugs and Treatment Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Bipolar Disorder Drugs and Treatment in 2021
3.2 Global Bipolar Disorder Drugs and Treatment Revenue by Manufacturers
3.2.1 Global Bipolar Disorder Drugs and Treatment Revenue by Manufacturers (2017-2022)
3.2.2 Global Bipolar Disorder Drugs and Treatment Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Bipolar Disorder Drugs and Treatment Revenue in 2021
3.3 Global Bipolar Disorder Drugs and Treatment Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Bipolar Disorder Drugs and Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Bipolar Disorder Drugs and Treatment Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Bipolar Disorder Drugs and Treatment Sales by Type
4.1.1 Global Bipolar Disorder Drugs and Treatment Historical Sales by Type (2017-2022)
4.1.2 Global Bipolar Disorder Drugs and Treatment Forecasted Sales by Type (2023-2028)
4.1.3 Global Bipolar Disorder Drugs and Treatment Sales Market Share by Type (2017-2028)
4.2 Global Bipolar Disorder Drugs and Treatment Revenue by Type
4.2.1 Global Bipolar Disorder Drugs and Treatment Historical Revenue by Type (2017-2022)
4.2.2 Global Bipolar Disorder Drugs and Treatment Forecasted Revenue by Type (2023-2028)
4.2.3 Global Bipolar Disorder Drugs and Treatment Revenue Market Share by Type (2017-2028)
4.3 Global Bipolar Disorder Drugs and Treatment Price by Type
4.3.1 Global Bipolar Disorder Drugs and Treatment Price by Type (2017-2022)
4.3.2 Global Bipolar Disorder Drugs and Treatment Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Bipolar Disorder Drugs and Treatment Sales by Application
5.1.1 Global Bipolar Disorder Drugs and Treatment Historical Sales by Application (2017-2022)
5.1.2 Global Bipolar Disorder Drugs and Treatment Forecasted Sales by Application (2023-2028)
5.1.3 Global Bipolar Disorder Drugs and Treatment Sales Market Share by Application (2017-2028)
5.2 Global Bipolar Disorder Drugs and Treatment Revenue by Application
5.2.1 Global Bipolar Disorder Drugs and Treatment Historical Revenue by Application (2017-2022)
5.2.2 Global Bipolar Disorder Drugs and Treatment Forecasted Revenue by Application (2023-2028)
5.2.3 Global Bipolar Disorder Drugs and Treatment Revenue Market Share by Application (2017-2028)
5.3 Global Bipolar Disorder Drugs and Treatment Price by Application
5.3.1 Global Bipolar Disorder Drugs and Treatment Price by Application (2017-2022)
5.3.2 Global Bipolar Disorder Drugs and Treatment Price Forecast by Application (2023-2028)
6 North America
6.1 North America Bipolar Disorder Drugs and Treatment Market Size by Type
6.1.1 North America Bipolar Disorder Drugs and Treatment Sales by Type (2017-2028)
6.1.2 North America Bipolar Disorder Drugs and Treatment Revenue by Type (2017-2028)
6.2 North America Bipolar Disorder Drugs and Treatment Market Size by Application
6.2.1 North America Bipolar Disorder Drugs and Treatment Sales by Application (2017-2028)
6.2.2 North America Bipolar Disorder Drugs and Treatment Revenue by Application (2017-2028)
6.3 North America Bipolar Disorder Drugs and Treatment Market Size by Country
6.3.1 North America Bipolar Disorder Drugs and Treatment Sales by Country (2017-2028)
6.3.2 North America Bipolar Disorder Drugs and Treatment Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Bipolar Disorder Drugs and Treatment Market Size by Type
7.1.1 Europe Bipolar Disorder Drugs and Treatment Sales by Type (2017-2028)
7.1.2 Europe Bipolar Disorder Drugs and Treatment Revenue by Type (2017-2028)
7.2 Europe Bipolar Disorder Drugs and Treatment Market Size by Application
7.2.1 Europe Bipolar Disorder Drugs and Treatment Sales by Application (2017-2028)
7.2.2 Europe Bipolar Disorder Drugs and Treatment Revenue by Application (2017-2028)
7.3 Europe Bipolar Disorder Drugs and Treatment Market Size by Country
7.3.1 Europe Bipolar Disorder Drugs and Treatment Sales by Country (2017-2028)
7.3.2 Europe Bipolar Disorder Drugs and Treatment Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Bipolar Disorder Drugs and Treatment Market Size by Type
8.1.1 Asia Pacific Bipolar Disorder Drugs and Treatment Sales by Type (2017-2028)
8.1.2 Asia Pacific Bipolar Disorder Drugs and Treatment Revenue by Type (2017-2028)
8.2 Asia Pacific Bipolar Disorder Drugs and Treatment Market Size by Application
8.2.1 Asia Pacific Bipolar Disorder Drugs and Treatment Sales by Application (2017-2028)
8.2.2 Asia Pacific Bipolar Disorder Drugs and Treatment Revenue by Application (2017-2028)
8.3 Asia Pacific Bipolar Disorder Drugs and Treatment Market Size by Region
8.3.1 Asia Pacific Bipolar Disorder Drugs and Treatment Sales by Region (2017-2028)
8.3.2 Asia Pacific Bipolar Disorder Drugs and Treatment Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Bipolar Disorder Drugs and Treatment Market Size by Type
9.1.1 Latin America Bipolar Disorder Drugs and Treatment Sales by Type (2017-2028)
9.1.2 Latin America Bipolar Disorder Drugs and Treatment Revenue by Type (2017-2028)
9.2 Latin America Bipolar Disorder Drugs and Treatment Market Size by Application
9.2.1 Latin America Bipolar Disorder Drugs and Treatment Sales by Application (2017-2028)
9.2.2 Latin America Bipolar Disorder Drugs and Treatment Revenue by Application (2017-2028)
9.3 Latin America Bipolar Disorder Drugs and Treatment Market Size by Country
9.3.1 Latin America Bipolar Disorder Drugs and Treatment Sales by Country (2017-2028)
9.3.2 Latin America Bipolar Disorder Drugs and Treatment Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Bipolar Disorder Drugs and Treatment Market Size by Type
10.1.1 Middle East and Africa Bipolar Disorder Drugs and Treatment Sales by Type (2017-2028)
10.1.2 Middle East and Africa Bipolar Disorder Drugs and Treatment Revenue by Type (2017-2028)
10.2 Middle East and Africa Bipolar Disorder Drugs and Treatment Market Size by Application
10.2.1 Middle East and Africa Bipolar Disorder Drugs and Treatment Sales by Application (2017-2028)
10.2.2 Middle East and Africa Bipolar Disorder Drugs and Treatment Revenue by Application (2017-2028)
10.3 Middle East and Africa Bipolar Disorder Drugs and Treatment Market Size by Country
10.3.1 Middle East and Africa Bipolar Disorder Drugs and Treatment Sales by Country (2017-2028)
10.3.2 Middle East and Africa Bipolar Disorder Drugs and Treatment Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 AbbVie Inc.
11.1.1 AbbVie Inc. Corporation Information
11.1.2 AbbVie Inc. Overview
11.1.3 AbbVie Inc. Bipolar Disorder Drugs and Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 AbbVie Inc. Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AbbVie Inc. Recent Developments
11.2 Glaxo SmithKline (GSK)
11.2.1 Glaxo SmithKline (GSK) Corporation Information
11.2.2 Glaxo SmithKline (GSK) Overview
11.2.3 Glaxo SmithKline (GSK) Bipolar Disorder Drugs and Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Glaxo SmithKline (GSK) Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Glaxo SmithKline (GSK) Recent Developments
11.3 Eli Lily and Company
11.3.1 Eli Lily and Company Corporation Information
11.3.2 Eli Lily and Company Overview
11.3.3 Eli Lily and Company Bipolar Disorder Drugs and Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Eli Lily and Company Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Eli Lily and Company Recent Developments
11.4 Janssen Pharmaceuticals
11.4.1 Janssen Pharmaceuticals Corporation Information
11.4.2 Janssen Pharmaceuticals Overview
11.4.3 Janssen Pharmaceuticals Bipolar Disorder Drugs and Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Janssen Pharmaceuticals Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Janssen Pharmaceuticals Recent Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Corporation Information
11.5.2 Johnson & Johnson Overview
11.5.3 Johnson & Johnson Bipolar Disorder Drugs and Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Johnson & Johnson Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Johnson & Johnson Recent Developments
11.6 Astellas Pharma Inc
11.6.1 Astellas Pharma Inc Corporation Information
11.6.2 Astellas Pharma Inc Overview
11.6.3 Astellas Pharma Inc Bipolar Disorder Drugs and Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Astellas Pharma Inc Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Astellas Pharma Inc Recent Developments
11.7 Bristol Myers Squibb
11.7.1 Bristol Myers Squibb Corporation Information
11.7.2 Bristol Myers Squibb Overview
11.7.3 Bristol Myers Squibb Bipolar Disorder Drugs and Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Bristol Myers Squibb Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Bristol Myers Squibb Recent Developments
11.8 Gedeon Richter PLC.
11.8.1 Gedeon Richter PLC. Corporation Information
11.8.2 Gedeon Richter PLC. Overview
11.8.3 Gedeon Richter PLC. Bipolar Disorder Drugs and Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Gedeon Richter PLC. Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Gedeon Richter PLC. Recent Developments
11.9 H. Lundbeck A/S
11.9.1 H. Lundbeck A/S Corporation Information
11.9.2 H. Lundbeck A/S Overview
11.9.3 H. Lundbeck A/S Bipolar Disorder Drugs and Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 H. Lundbeck A/S Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 H. Lundbeck A/S Recent Developments
11.10 Pfizer Inc.
11.10.1 Pfizer Inc. Corporation Information
11.10.2 Pfizer Inc. Overview
11.10.3 Pfizer Inc. Bipolar Disorder Drugs and Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Pfizer Inc. Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Pfizer Inc. Recent Developments
11.11 Novartis AG
11.11.1 Novartis AG Corporation Information
11.11.2 Novartis AG Overview
11.11.3 Novartis AG Bipolar Disorder Drugs and Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Novartis AG Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Novartis AG Recent Developments
11.12 Otsuka Holdings Co. Ltd
11.12.1 Otsuka Holdings Co. Ltd Corporation Information
11.12.2 Otsuka Holdings Co. Ltd Overview
11.12.3 Otsuka Holdings Co. Ltd Bipolar Disorder Drugs and Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Otsuka Holdings Co. Ltd Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Otsuka Holdings Co. Ltd Recent Developments
11.13 Validus Pharmaceuticals LLC.
11.13.1 Validus Pharmaceuticals LLC. Corporation Information
11.13.2 Validus Pharmaceuticals LLC. Overview
11.13.3 Validus Pharmaceuticals LLC. Bipolar Disorder Drugs and Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Validus Pharmaceuticals LLC. Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Validus Pharmaceuticals LLC. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Bipolar Disorder Drugs and Treatment Industry Chain Analysis
12.2 Bipolar Disorder Drugs and Treatment Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Bipolar Disorder Drugs and Treatment Production Mode & Process
12.4 Bipolar Disorder Drugs and Treatment Sales and Marketing
12.4.1 Bipolar Disorder Drugs and Treatment Sales Channels
12.4.2 Bipolar Disorder Drugs and Treatment Distributors
12.5 Bipolar Disorder Drugs and Treatment Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Bipolar Disorder Drugs and Treatment Industry Trends
13.2 Bipolar Disorder Drugs and Treatment Market Drivers
13.3 Bipolar Disorder Drugs and Treatment Market Challenges
13.4 Bipolar Disorder Drugs and Treatment Market Restraints
14 Key Findings in The Global Bipolar Disorder Drugs and Treatment Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Bipolar Disorder Drugs and Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Mood Stabilizers
Table 3. Major Manufacturers of Anticonvulsants
Table 4. Major Manufacturers of Antipsychotic Drugs
Table 5. Major Manufacturers of Antidepressant Drugs
Table 6. Major Manufacturers of Anti-Anxiety Drugs
Table 7. Global Bipolar Disorder Drugs and Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Bipolar Disorder Drugs and Treatment Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Bipolar Disorder Drugs and Treatment Sales by Region (2017-2022) & (K Units)
Table 10. Global Bipolar Disorder Drugs and Treatment Sales Market Share by Region (2017-2022)
Table 11. Global Bipolar Disorder Drugs and Treatment Sales by Region (2023-2028) & (K Units)
Table 12. Global Bipolar Disorder Drugs and Treatment Sales Market Share by Region (2023-2028)
Table 13. Global Bipolar Disorder Drugs and Treatment Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global Bipolar Disorder Drugs and Treatment Revenue Market Share by Region (2017-2022)
Table 15. Global Bipolar Disorder Drugs and Treatment Revenue by Region (2023-2028) & (US$ Million)
Table 16. Global Bipolar Disorder Drugs and Treatment Revenue Market Share by Region (2023-2028)
Table 17. Global Bipolar Disorder Drugs and Treatment Sales by Manufacturers (2017-2022) & (K Units)
Table 18. Global Bipolar Disorder Drugs and Treatment Sales Share by Manufacturers (2017-2022)
Table 19. Global Bipolar Disorder Drugs and Treatment Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 20. Global Bipolar Disorder Drugs and Treatment Revenue Share by Manufacturers (2017-2022)
Table 21. Bipolar Disorder Drugs and Treatment Price by Manufacturers (2017-2022) &(US$/Unit)
Table 22. Global Bipolar Disorder Drugs and Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Bipolar Disorder Drugs and Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bipolar Disorder Drugs and Treatment as of 2021)
Table 24. Bipolar Disorder Drugs and Treatment Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Bipolar Disorder Drugs and Treatment Product Offered
Table 26. Date of Manufacturers Enter into Bipolar Disorder Drugs and Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Bipolar Disorder Drugs and Treatment Sales by Type (2017-2022) & (K Units)
Table 29. Global Bipolar Disorder Drugs and Treatment Sales by Type (2023-2028) & (K Units)
Table 30. Global Bipolar Disorder Drugs and Treatment Sales Share by Type (2017-2022)
Table 31. Global Bipolar Disorder Drugs and Treatment Sales Share by Type (2023-2028)
Table 32. Global Bipolar Disorder Drugs and Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 33. Global Bipolar Disorder Drugs and Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 34. Global Bipolar Disorder Drugs and Treatment Revenue Share by Type (2017-2022)
Table 35. Global Bipolar Disorder Drugs and Treatment Revenue Share by Type (2023-2028)
Table 36. Bipolar Disorder Drugs and Treatment Price by Type (2017-2022) & (US$/Unit)
Table 37. Global Bipolar Disorder Drugs and Treatment Price Forecast by Type (2023-2028) & (US$/Unit)
Table 38. Global Bipolar Disorder Drugs and Treatment Sales by Application (2017-2022) & (K Units)
Table 39. Global Bipolar Disorder Drugs and Treatment Sales by Application (2023-2028) & (K Units)
Table 40. Global Bipolar Disorder Drugs and Treatment Sales Share by Application (2017-2022)
Table 41. Global Bipolar Disorder Drugs and Treatment Sales Share by Application (2023-2028)
Table 42. Global Bipolar Disorder Drugs and Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 43. Global Bipolar Disorder Drugs and Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 44. Global Bipolar Disorder Drugs and Treatment Revenue Share by Application (2017-2022)
Table 45. Global Bipolar Disorder Drugs and Treatment Revenue Share by Application (2023-2028)
Table 46. Bipolar Disorder Drugs and Treatment Price by Application (2017-2022) & (US$/Unit)
Table 47. Global Bipolar Disorder Drugs and Treatment Price Forecast by Application (2023-2028) & (US$/Unit)
Table 48. North America Bipolar Disorder Drugs and Treatment Sales by Type (2017-2022) & (K Units)
Table 49. North America Bipolar Disorder Drugs and Treatment Sales by Type (2023-2028) & (K Units)
Table 50. North America Bipolar Disorder Drugs and Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 51. North America Bipolar Disorder Drugs and Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 52. North America Bipolar Disorder Drugs and Treatment Sales by Application (2017-2022) & (K Units)
Table 53. North America Bipolar Disorder Drugs and Treatment Sales by Application (2023-2028) & (K Units)
Table 54. North America Bipolar Disorder Drugs and Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 55. North America Bipolar Disorder Drugs and Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 56. North America Bipolar Disorder Drugs and Treatment Sales by Country (2017-2022) & (K Units)
Table 57. North America Bipolar Disorder Drugs and Treatment Sales by Country (2023-2028) & (K Units)
Table 58. North America Bipolar Disorder Drugs and Treatment Revenue by Country (2017-2022) & (US$ Million)
Table 59. North America Bipolar Disorder Drugs and Treatment Revenue by Country (2023-2028) & (US$ Million)
Table 60. Europe Bipolar Disorder Drugs and Treatment Sales by Type (2017-2022) & (K Units)
Table 61. Europe Bipolar Disorder Drugs and Treatment Sales by Type (2023-2028) & (K Units)
Table 62. Europe Bipolar Disorder Drugs and Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 63. Europe Bipolar Disorder Drugs and Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 64. Europe Bipolar Disorder Drugs and Treatment Sales by Application (2017-2022) & (K Units)
Table 65. Europe Bipolar Disorder Drugs and Treatment Sales by Application (2023-2028) & (K Units)
Table 66. Europe Bipolar Disorder Drugs and Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 67. Europe Bipolar Disorder Drugs and Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 68. Europe Bipolar Disorder Drugs and Treatment Sales by Country (2017-2022) & (K Units)
Table 69. Europe Bipolar Disorder Drugs and Treatment Sales by Country (2023-2028) & (K Units)
Table 70. Europe Bipolar Disorder Drugs and Treatment Revenue by Country (2017-2022) & (US$ Million)
Table 71. Europe Bipolar Disorder Drugs and Treatment Revenue by Country (2023-2028) & (US$ Million)
Table 72. Asia Pacific Bipolar Disorder Drugs and Treatment Sales by Type (2017-2022) & (K Units)
Table 73. Asia Pacific Bipolar Disorder Drugs and Treatment Sales by Type (2023-2028) & (K Units)
Table 74. Asia Pacific Bipolar Disorder Drugs and Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 75. Asia Pacific Bipolar Disorder Drugs and Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 76. Asia Pacific Bipolar Disorder Drugs and Treatment Sales by Application (2017-2022) & (K Units)
Table 77. Asia Pacific Bipolar Disorder Drugs and Treatment Sales by Application (2023-2028) & (K Units)
Table 78. Asia Pacific Bipolar Disorder Drugs and Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 79. Asia Pacific Bipolar Disorder Drugs and Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 80. Asia Pacific Bipolar Disorder Drugs and Treatment Sales by Region (2017-2022) & (K Units)
Table 81. Asia Pacific Bipolar Disorder Drugs and Treatment Sales by Region (2023-2028) & (K Units)
Table 82. Asia Pacific Bipolar Disorder Drugs and Treatment Revenue by Region (2017-2022) & (US$ Million)
Table 83. Asia Pacific Bipolar Disorder Drugs and Treatment Revenue by Region (2023-2028) & (US$ Million)
Table 84. Latin America Bipolar Disorder Drugs and Treatment Sales by Type (2017-2022) & (K Units)
Table 85. Latin America Bipolar Disorder Drugs and Treatment Sales by Type (2023-2028) & (K Units)
Table 86. Latin America Bipolar Disorder Drugs and Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 87. Latin America Bipolar Disorder Drugs and Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 88. Latin America Bipolar Disorder Drugs and Treatment Sales by Application (2017-2022) & (K Units)
Table 89. Latin America Bipolar Disorder Drugs and Treatment Sales by Application (2023-2028) & (K Units)
Table 90. Latin America Bipolar Disorder Drugs and Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 91. Latin America Bipolar Disorder Drugs and Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 92. Latin America Bipolar Disorder Drugs and Treatment Sales by Country (2017-2022) & (K Units)
Table 93. Latin America Bipolar Disorder Drugs and Treatment Sales by Country (2023-2028) & (K Units)
Table 94. Latin America Bipolar Disorder Drugs and Treatment Revenue by Country (2017-2022) & (US$ Million)
Table 95. Latin America Bipolar Disorder Drugs and Treatment Revenue by Country (2023-2028) & (US$ Million)
Table 96. Middle East and Africa Bipolar Disorder Drugs and Treatment Sales by Type (2017-2022) & (K Units)
Table 97. Middle East and Africa Bipolar Disorder Drugs and Treatment Sales by Type (2023-2028) & (K Units)
Table 98. Middle East and Africa Bipolar Disorder Drugs and Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 99. Middle East and Africa Bipolar Disorder Drugs and Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Bipolar Disorder Drugs and Treatment Sales by Application (2017-2022) & (K Units)
Table 101. Middle East and Africa Bipolar Disorder Drugs and Treatment Sales by Application (2023-2028) & (K Units)
Table 102. Middle East and Africa Bipolar Disorder Drugs and Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Bipolar Disorder Drugs and Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Bipolar Disorder Drugs and Treatment Sales by Country (2017-2022) & (K Units)
Table 105. Middle East and Africa Bipolar Disorder Drugs and Treatment Sales by Country (2023-2028) & (K Units)
Table 106. Middle East and Africa Bipolar Disorder Drugs and Treatment Revenue by Country (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Bipolar Disorder Drugs and Treatment Revenue by Country (2023-2028) & (US$ Million)
Table 108. AbbVie Inc. Corporation Information
Table 109. AbbVie Inc. Description and Major Businesses
Table 110. AbbVie Inc. Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 111. AbbVie Inc. Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. AbbVie Inc. Recent Developments
Table 113. Glaxo SmithKline (GSK) Corporation Information
Table 114. Glaxo SmithKline (GSK) Description and Major Businesses
Table 115. Glaxo SmithKline (GSK) Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 116. Glaxo SmithKline (GSK) Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Glaxo SmithKline (GSK) Recent Developments
Table 118. Eli Lily and Company Corporation Information
Table 119. Eli Lily and Company Description and Major Businesses
Table 120. Eli Lily and Company Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 121. Eli Lily and Company Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Eli Lily and Company Recent Developments
Table 123. Janssen Pharmaceuticals Corporation Information
Table 124. Janssen Pharmaceuticals Description and Major Businesses
Table 125. Janssen Pharmaceuticals Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 126. Janssen Pharmaceuticals Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Janssen Pharmaceuticals Recent Developments
Table 128. Johnson & Johnson Corporation Information
Table 129. Johnson & Johnson Description and Major Businesses
Table 130. Johnson & Johnson Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 131. Johnson & Johnson Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Johnson & Johnson Recent Developments
Table 133. Astellas Pharma Inc Corporation Information
Table 134. Astellas Pharma Inc Description and Major Businesses
Table 135. Astellas Pharma Inc Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 136. Astellas Pharma Inc Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Astellas Pharma Inc Recent Developments
Table 138. Bristol Myers Squibb Corporation Information
Table 139. Bristol Myers Squibb Description and Major Businesses
Table 140. Bristol Myers Squibb Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 141. Bristol Myers Squibb Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Bristol Myers Squibb Recent Developments
Table 143. Gedeon Richter PLC. Corporation Information
Table 144. Gedeon Richter PLC. Description and Major Businesses
Table 145. Gedeon Richter PLC. Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 146. Gedeon Richter PLC. Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Gedeon Richter PLC. Recent Developments
Table 148. H. Lundbeck A/S Corporation Information
Table 149. H. Lundbeck A/S Description and Major Businesses
Table 150. H. Lundbeck A/S Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 151. H. Lundbeck A/S Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. H. Lundbeck A/S Recent Developments
Table 153. Pfizer Inc. Corporation Information
Table 154. Pfizer Inc. Description and Major Businesses
Table 155. Pfizer Inc. Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 156. Pfizer Inc. Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Pfizer Inc. Recent Developments
Table 158. Novartis AG Corporation Information
Table 159. Novartis AG Description and Major Businesses
Table 160. Novartis AG Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 161. Novartis AG Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. Novartis AG Recent Developments
Table 163. Otsuka Holdings Co. Ltd Corporation Information
Table 164. Otsuka Holdings Co. Ltd Description and Major Businesses
Table 165. Otsuka Holdings Co. Ltd Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 166. Otsuka Holdings Co. Ltd Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. Otsuka Holdings Co. Ltd Recent Developments
Table 168. Validus Pharmaceuticals LLC. Corporation Information
Table 169. Validus Pharmaceuticals LLC. Description and Major Businesses
Table 170. Validus Pharmaceuticals LLC. Bipolar Disorder Drugs and Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 171. Validus Pharmaceuticals LLC. Bipolar Disorder Drugs and Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 172. Validus Pharmaceuticals LLC. Recent Developments
Table 173. Key Raw Materials Lists
Table 174. Raw Materials Key Suppliers Lists
Table 175. Bipolar Disorder Drugs and Treatment Distributors List
Table 176. Bipolar Disorder Drugs and Treatment Customers List
Table 177. Bipolar Disorder Drugs and Treatment Market Trends
Table 178. Bipolar Disorder Drugs and Treatment Market Drivers
Table 179. Bipolar Disorder Drugs and Treatment Market Challenges
Table 180. Bipolar Disorder Drugs and Treatment Market Restraints
Table 181. Research Programs/Design for This Report
Table 182. Key Data Information from Secondary Sources
Table 183. Key Data Information from Primary Sources
List of Figures
Figure 1. Bipolar Disorder Drugs and Treatment Product Picture
Figure 3. Global Bipolar Disorder Drugs and Treatment Market Share by Type in 2021 & 2028
Figure 3. Mood Stabilizers Product Picture
Figure 4. Anticonvulsants Product Picture
Figure 5. Antipsychotic Drugs Product Picture
Figure 6. Antidepressant Drugs Product Picture
Figure 7. Anti-Anxiety Drugs Product Picture
Figure 8. Global Bipolar Disorder Drugs and Treatment Market Share by Application in 2021 & 2028
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Bipolar Disorder Drugs and Treatment Report Years Considered
Figure 12. Global Bipolar Disorder Drugs and Treatment Sales 2017-2028 (K Units)
Figure 13. Global Bipolar Disorder Drugs and Treatment Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Bipolar Disorder Drugs and Treatment Revenue 2017-2028 (US$ Million)
Figure 15. Global Bipolar Disorder Drugs and Treatment Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Bipolar Disorder Drugs and Treatment Sales Market Share by Region (2017-2022)
Figure 17. Global Bipolar Disorder Drugs and Treatment Sales Market Share by Region (2023-2028)
Figure 18. North America Bipolar Disorder Drugs and Treatment Sales YoY (2017-2028) & (K Units)
Figure 19. North America Bipolar Disorder Drugs and Treatment Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Bipolar Disorder Drugs and Treatment Sales YoY (2017-2028) & (K Units)
Figure 21. Europe Bipolar Disorder Drugs and Treatment Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Bipolar Disorder Drugs and Treatment Sales YoY (2017-2028) & (K Units)
Figure 23. Asia-Pacific Bipolar Disorder Drugs and Treatment Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Bipolar Disorder Drugs and Treatment Sales YoY (2017-2028) & (K Units)
Figure 25. Latin America Bipolar Disorder Drugs and Treatment Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Bipolar Disorder Drugs and Treatment Sales YoY (2017-2028) & (K Units)
Figure 27. Middle East & Africa Bipolar Disorder Drugs and Treatment Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Bipolar Disorder Drugs and Treatment Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Bipolar Disorder Drugs and Treatment in the World: Market Share by Bipolar Disorder Drugs and Treatment Revenue in 2021
Figure 30. Global Bipolar Disorder Drugs and Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Bipolar Disorder Drugs and Treatment Sales Market Share by Type (2017-2028)
Figure 32. Global Bipolar Disorder Drugs and Treatment Revenue Market Share by Type (2017-2028)
Figure 33. Global Bipolar Disorder Drugs and Treatment Sales Market Share by Application (2017-2028)
Figure 34. Global Bipolar Disorder Drugs and Treatment Revenue Market Share by Application (2017-2028)
Figure 35. North America Bipolar Disorder Drugs and Treatment Sales Market Share by Type (2017-2028)
Figure 36. North America Bipolar Disorder Drugs and Treatment Revenue Market Share by Type (2017-2028)
Figure 37. North America Bipolar Disorder Drugs and Treatment Sales Market Share by Application (2017-2028)
Figure 38. North America Bipolar Disorder Drugs and Treatment Revenue Market Share by Application (2017-2028)
Figure 39. North America Bipolar Disorder Drugs and Treatment Sales Share by Country (2017-2028)
Figure 40. North America Bipolar Disorder Drugs and Treatment Revenue Share by Country (2017-2028)
Figure 41. United States Bipolar Disorder Drugs and Treatment Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Bipolar Disorder Drugs and Treatment Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Bipolar Disorder Drugs and Treatment Sales Market Share by Type (2017-2028)
Figure 44. Europe Bipolar Disorder Drugs and Treatment Revenue Market Share by Type (2017-2028)
Figure 45. Europe Bipolar Disorder Drugs and Treatment Sales Market Share by Application (2017-2028)
Figure 46. Europe Bipolar Disorder Drugs and Treatment Revenue Market Share by Application (2017-2028)
Figure 47. Europe Bipolar Disorder Drugs and Treatment Sales Share by Country (2017-2028)
Figure 48. Europe Bipolar Disorder Drugs and Treatment Revenue Share by Country (2017-2028)
Figure 49. Germany Bipolar Disorder Drugs and Treatment Revenue (2017-2028) & (US$ Million)
Figure 50. France Bipolar Disorder Drugs and Treatment Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Bipolar Disorder Drugs and Treatment Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Bipolar Disorder Drugs and Treatment Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Bipolar Disorder Drugs and Treatment Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Bipolar Disorder Drugs and Treatment Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Bipolar Disorder Drugs and Treatment Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Bipolar Disorder Drugs and Treatment Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Bipolar Disorder Drugs and Treatment Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Bipolar Disorder Drugs and Treatment Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Bipolar Disorder Drugs and Treatment Revenue Share by Region (2017-2028)
Figure 60. China Bipolar Disorder Drugs and Treatment Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Bipolar Disorder Drugs and Treatment Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Bipolar Disorder Drugs and Treatment Revenue (2017-2028) & (US$ Million)
Figure 63. India Bipolar Disorder Drugs and Treatment Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Bipolar Disorder Drugs and Treatment Revenue (2017-2028) & (US$ Million)
Figure 65. China Taiwan Bipolar Disorder Drugs and Treatment Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Bipolar Disorder Drugs and Treatment Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Bipolar Disorder Drugs and Treatment Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Bipolar Disorder Drugs and Treatment Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Bipolar Disorder Drugs and Treatment Sales Market Share by Type (2017-2028)
Figure 70. Latin America Bipolar Disorder Drugs and Treatment Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Bipolar Disorder Drugs and Treatment Sales Market Share by Application (2017-2028)
Figure 72. Latin America Bipolar Disorder Drugs and Treatment Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Bipolar Disorder Drugs and Treatment Sales Share by Country (2017-2028)
Figure 74. Latin America Bipolar Disorder Drugs and Treatment Revenue Share by Country (2017-2028)
Figure 75. Mexico Bipolar Disorder Drugs and Treatment Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Bipolar Disorder Drugs and Treatment Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Bipolar Disorder Drugs and Treatment Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Bipolar Disorder Drugs and Treatment Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Bipolar Disorder Drugs and Treatment Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Bipolar Disorder Drugs and Treatment Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Bipolar Disorder Drugs and Treatment Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Bipolar Disorder Drugs and Treatment Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Bipolar Disorder Drugs and Treatment Revenue Share by Country (2017-2028)
Figure 84. Turkey Bipolar Disorder Drugs and Treatment Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Bipolar Disorder Drugs and Treatment Revenue (2017-2028) & (US$ Million)
Figure 86. UAE Bipolar Disorder Drugs and Treatment Revenue (2017-2028) & (US$ Million)
Figure 87. Bipolar Disorder Drugs and Treatment Value Chain
Figure 88. Bipolar Disorder Drugs and Treatment Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed

---